• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NAVIGATION, INC (LITTLETON) MEDTRONIC NAVIGATION; IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, MOBILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NAVIGATION, INC (LITTLETON) MEDTRONIC NAVIGATION; IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, MOBILE Back to Search Results
Model Number UNK_OARM_SYS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Unspecified Infection (1930)
Event Date 06/08/2020
Event Type  Injury  
Manufacturer Narrative
Patient age is the mean value of patients in the study.Patient sex not available from the site.Patient weight not available from the site.Event date is the accepted date of the publication.Device lot number, or serial number, unavailable.No parts have been received by the manufacturer for evaluation.Device manufacturing date is dependent on lot number/serial number, therefore, unavailable.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Citation: catherine h.Moran, md, mariusz pietrzyk, phd, nagaraja sarangmat, md, carter s.Gerard, md, neil barua, phd, reiko ashida, md, alan whone, phd, konrad szewczyk-krolikowski, phd, lucy mooney, bsc, steven s.Gill, ms.Clinical outcome of "asleep" deep brain stimulation for parkinson disease using robot-assisted delivery and anatomic targeting of the subthalamic nucleus: a series of 152 patients.Neurosurgery, 2020.Doi:10.1093/neuros/nyaa367 abstract: background: recent advances in methods used for deep brain stimulation (dbs) include subthalamic nucleus electrode implantation in the ¿asleep¿ patient without the traditional use of microelectrode recordings or intraoperative test stimulation.Objective: to examine the clinical outcome of patients who have undergone ¿asleep¿ dbs for the treatment of parkinson disease using robot-assisted electrode delivery.Methods: this is a retrospective review of clinical outcomes of 152 consecutive patients.Their outcomes at 1 yr postimplantation are reported; these include unified parkinson¿s disease rating scale (updrs) assessment, tinetti mobility test, parkinson¿s disease questionnaire (pdq)-39 quality of life assessment, mattis dementia rating scale, beck depression inventory, and beck anxiety.We also report on a new parietal trajectory for electrode implantation.Results: a total of 152 patients underwent assessment at 1 yr.Updrs iii improved from 39 to 20.5 (47%, p <.001).The total updrs score improved from 67.6 to 36.4 (46%, p <.001).Updrs ii scores improved from 18.9 to 10.5 (44%, p <.001) and updrs iv scores improved from7.1 to 3.6 (49%, p<.001).There was a significant reduction in levodopa equivalent daily dose after surgery (mean: 35%, p <.001).Pdq-39 summary index improved by a mean of 7.1 points.There was no significant difference found in clinical outcomes between the frontal and parietal approaches.Conclusion: ¿asleep¿ robot-assisted dbs of the subthalamic nucleus demonstrates comparable outcomes with traditional techniques in the treatment of parkinson disease.Reported events: three patients experienced an infection requiring removal of the entire deep brain stimulation (dbs) system.Two superficial parenchymal intraoperative hemorrhages were reported to have occurred and were managed conservatively.One patient was noted to have required re-operation for evacuation of an ipg site hematoma.One patient was admitted for an overdose of prescription drug.One patient developed post-operative psychosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC NAVIGATION
Type of Device
IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, MOBILE
Manufacturer (Section D)
MEDTRONIC NAVIGATION, INC (LITTLETON)
300 foster st
littleton MA 01460
Manufacturer (Section G)
MEDTRONIC NAVIGATION, INC (LITTLETON)
300 foster st
littleton MA 01460
Manufacturer Contact
tricha miles
7000 central avenue ne rcw215
minneapolis, MN 55432
7635140379
MDR Report Key10924327
MDR Text Key219179756
Report Number3004785967-2020-01432
Device Sequence Number1
Product Code OXO
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
K050996
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 11/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK_OARM_SYS
Device Catalogue NumberUNK_OARM_SYS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/19/2020
Initial Date FDA Received11/30/2020
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age60 YR
-
-